Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin plus first-line chemotherapy in small cell lung cancer
2005-005821-71Phase 3Terminated
- Sponsor
- University College London
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in small cell lung cancer (SCLC) comparing Pravastatin arm with Placebo arm (2 arms). Primary endpoint: Overall survival. Started Mar 2006; status: terminated.
02
Drugs
pravastatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2005-005821-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005821-71.